Home Cart 0 Sign in  
X

[ CAS No. 2913-97-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2913-97-5
Chemical Structure| 2913-97-5
Chemical Structure| 2913-97-5
Structure of 2913-97-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2913-97-5 ]

Related Doc. of [ 2913-97-5 ]

Alternatived Products of [ 2913-97-5 ]

Product Details of [ 2913-97-5 ]

CAS No. :2913-97-5 MDL No. :MFCD00023080
Formula : C10H7NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :LMRDBJZQDUVCQH-UHFFFAOYSA-N
M.W : 189.17 Pubchem ID :76201
Synonyms :

Calculated chemistry of [ 2913-97-5 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.1
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 51.73
TPSA : 54.45 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.16
Log Po/w (XLOGP3) : 0.84
Log Po/w (WLOGP) : 0.1
Log Po/w (MLOGP) : 0.53
Log Po/w (SILICOS-IT) : 1.41
Consensus Log Po/w : 0.81

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.73
Solubility : 3.55 mg/ml ; 0.0187 mol/l
Class : Very soluble
Log S (Ali) : -1.57
Solubility : 5.13 mg/ml ; 0.0271 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.42
Solubility : 0.723 mg/ml ; 0.00382 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.29

Safety of [ 2913-97-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2913-97-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2913-97-5 ]
  • Downstream synthetic route of [ 2913-97-5 ]

[ 2913-97-5 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 78902-09-7 ]
  • [ 2913-97-5 ]
YieldReaction ConditionsOperation in experiment
99% for 1 h; Heating / reflux Example 5 : Preparation of N-2-[4-(4-bromo-2-fluoro-phenylamino)-7-(l- methyl-piperidin-4-ylmethoxy)-quinazolin-6-ylamino]-ethyl-acrylamide<5-l> (l,3-dioxo-l,3-dihydro-isoindol-2-yl)-acetaldehyde; Phthalimidoacetaldehyde diethylacetal (1O g, 0.0379 mol) was dissolved in 100 ml of 1 N HCl aqueous solution, and the resulting solution was refluxed and stirred for 1 hour. When the reaction was terminated, the reacted solution was extracted with 200 mi of dichloromethane, washed with 100 mi of salt solution, and distilled under a reduced pressure to obtain the title compound 7.16 g (yield: 99percent).1H NMR (CDCl3) δ: 9.66 (s, IH), 7.90-7.84 (m, 2H), 7.78-7.73 (m, 2H), 4.56 (s, 2H).
95% at 60℃; for 24 h; Compound 1: HCl (0.1 N, 42 mL) was added to a solution of phthalimidoacetaldehyde diethyl acetal (4.18 g, 15.1 mmol) in AcOH (42 mL). The resulting suspension was heated at 60°C for 24 h. The solvent was evaporated and the mixture was dissolved in CH2Cl2. The organic phase was washed with sat. aq NaHCO3, H2O, dried over MgSO4 and evaporated to afford the title compound as a brown solid (2.72 g, 95 percent). The physical data are consistent with the previously reported ones.
95% With hydrogenchloride; acetic acid In water at 60℃; for 24 h; Compound 1 : HC1 (0.1 N, 42 mL) was added to a solution of phthalimidoacetaldehyde diethyl acetal (4.18 g, 15.1 mmol) in AcOH (42 mL). The resulting suspension was heated at 60°C for 24 h. The solvent was evaporated and the mixture was dissolved in CH2CI2. The organic phase was washed with sat. aq NaHC03, H20, dried over MgS04 and evaporated to afford the title compound as a brown solid (2.72 g, 95 percent). The physical data are consistent with the previously reported ones.
93% With trifluoroacetic acid In chloroform at 20℃; for 6 h; Inert atmosphere; Cooling with ice Compound 2 was prepared according to a modified method of Veale et al. (E. B. Veale, J. E. O'Brien, T. McCabe and T. Gunnlaugsson, Tetrahedron, 2008, 64, 6794-6800). In an ice/water bath, under a nitrogen atmosphere, to a solution of phthalimido-acetaldehydediethylacetal (13 g, 49 mmol) in CHCl3 (150 mL), TFA (100 mL) was added. The resulting solution was stirred for 1 h. Then the ice bath was removed and the reaction mixture was stirred at r.t. for a further 5 h. The solvent was removed in vacuo and co-evaporated with CH2Cl2 several times to remove the remaining traces of TFA. This yielded the product (Compound 2) as an off-white solid (9 g, 93percent). No purification was necessary. 1H NMR (CDCl3, 400 MHz) δ 9.68 (s, 1H, CHO), 7.91 (m, 2H), 7.78 (m, 2H), 4.59 (s, 2H); 13C NMR (CDCl3, 100 MHz): δ (100 MHz, CDCl3) 193.6, 167.6, 134.4, 131.9, 123.7, 47.4.
88% for 0.0833333 h; Heating / reflux EXAMPLE 28
7-(((Benzo[1,3]dioxole-5-carbonyl)amino)methyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid
Phthalimidoacetaldehyde diethyl acetal (100 g, 0.38 mol) and 1 N hydrochloric acid (600 ml) was mixture was stirred at reflux temperature for 5 min. or until a homogeneous solution is obtained.
The reaction mixture was cooled and the precipitate was filtered off and dried in vacuo at 50 °C for 16 hours, which afforded 63.3 g (88 percent) of phthalimido-acetaldehyde as a solid.
1H-NMR (300 MHz, CDCl3) δ 4.58 (s, 2H), 7.76 - 7.78(m, 2H), 7.90 - 7.92 (m, 2H), 9.67 (s, 1H).
88% for 0.0833333 h; Heating / reflux Example 28
7-(((Benzo[1,3]dioxole-5-carbonyl)amino)methyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid
Phthalimidoacetaldehyde diethyl acetal (100 g, 0.38 mol) and 1 N hydrochloric acid (600 ml) was mixture was stirred at reflux temperature for 5 min. or until a homogeneous solution is obtained.
The reaction mixture was cooled and the precipitate was filtered off and dried in vacuo at 50° C. for 16 hours, which afforded 63.3 g (88percent) of phthalimido-acetaldehyde as a solid.
1H-NMR (300 MHz, CDCl3) δ 4.58 (s, 2H), 7.76-7.78 (m, 2H), 7.90-7.92 (m, 2H), 9.67 (s, 1H).
88% for 0.0833333 h; Heating / reflux Example 28 7-(((Benzo[1,3]dioxole-5-carbonyl)-amino)-methyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid; Phthalimidoacetaldehyde diethyl acetal (100 g, 0.38 mol) and 1 N hydrochloric acid (600 ml) was mixture was stirred at reflux temperature for 5 min. or until a homogeneous solution is obtained. The reaction mixture was cooled and the precipitate was filtered off and dried in vacuo at 50° C. for 16 h which afforded 63.3 g (88percent) of phthalimidoacetaldehyde as a solid.1H NMR (300 MHz, CDCl3) δ 4.58 (s, 2H), 7.76-7.78 (m, 2H), 7.90-7.92 (m, 2H), 9.67 (s, 1H).To a mixture of phthalimidoacetaldehyde (64 g, 0.34 mol) and trans-1-methoxy-3-(trimethylsilyloxy)-1,3-butadiene (81.5 g, 0.38 mol) in benzene (600 ml) stirred for 15 min. under nitrogen was added dropwise a 45percent solution of zinc chloride diethyl ether complex in dichloromethane (55.5 ml, 0.17 mol) at 0° C. The reaction was allowed warm up to room temperature overnight. To the reaction mixture was added water (500 ml) and the resulting mixture was extracted with ethyl acetate (200 ml). The organic extract was washed successively with 1.0 N hydrochloric acid (2.x.200 ml) and brine (200 ml). The organic phase was dried (Na2SO4), filtered and the solvent evaporated in vacuo which afforded a slowly crystallising oil (98 g). To the solid was added a mixture of ethyl acetate and diethyl ether (400 ml, 1:1) and the resulting precipitate was filtered off, washed with a small portion of diethyl ether and dried at 50° C. for 1 h affording 59.8 g (69percent of 2-(4-oxo-3,4-dihydro-2H-pyran-2-ylmethyl)-isoindole-1,3-dione as a solid. The filtrate was evaporated in vacuo and the residue purified by column chromatography on silica gel (1 L) using a mixture of ethyl acetate and heptane (1:2) as eluant. Pure fractions were collected and the solvent evaporated in vacuo to almost dryness, the solid was filtered off and dried in vacuo at 50° C. for 16 h affording an additional 15 g (17percent) of 2-(4-oxo-3,4-dihydro-2H-pyran-2-ylmethyl)-isoindole-1,3-dione as a solid.1H NMR (300 MHz, CDCl3) δ 2.61 (d, 2H), 3.85 (dd, 1H), 4.18 (dd, 1H), 4.76 (m, 1H), 5.43 (d, 1H), 7.28 (d, 1H), 7.69-7.77 (m, 2H), 7.84-7.88 (m, 2H).2-(4-Oxo-3,4-dihydro-2H-pyran-2-ylmethyl)-isoindole-1,3-dione (13 g, 0.051 mol) was dissolved in ethyl acetate (250 ml) and placed in a Parr bottle. 10percent Pd/C (1.5 g) was carefully added and the mixture was shaken under a pressure of 30 psi of hydrogen for 6.5 h (Parr apparatus). Filtration followed by evaporation of the ethyl acetate in vacuo afforded a crude 11.5 g of 2-(4-oxo-tetrahydro-pyran-2-ylmethyl)-isoindole-1,3-dione pure enough for the next step. Analytical pure compound could be obtained by purification of a small sample (250 mg) by column chromatography on silica gel, utilising a mixture of hexane/ethyl acetate as a gradient (from 100/0 to 50/50). Pure fractions were collected and the solvent evaporated in vacuo affording 142 mg (55percent) of 2-(4-oxo-tetrahydro-pyran-2-ylmethyl)-isoindole-1,3-dione as a solid.1H NMR (400 MHz, CDCl3) δ 2.30-2.68 (m, 4H), 3.62 (m, 1H), 3.74 (m, 1H), 4.00 (m, 2H), 7.75 (m, 2H), 7.88 (m, 2H).To a mixture of 2-(4-oxo-tetrahydro-pyran-2-ylmethyl)-isoindole-1,3-dione (11.5 g, 44 mmol), tert-butyl cyanoacetate (6.9 g, 49 mmol) and elemental sulfur (1.6 g, 49 mmol) in ethanol (250 ml) was added morpholin (15 ml) and the resulting mixture was stirred at 50° C. for 16 h. The cooled reaction mixture was filtered and the precipitate filtered off and washed with diethyl ether and dried in vacuo affording 6.5 g (35percent) of 2-amino-5-(1,3-dioxo-1,3-dihydro-isoindol-2-ylmethyl)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester as a solid.The filtrate was evaporated in vacuo and the residue was dissolved in ethyl acetate (200 ml) washed with water (2.x.100 ml), brine (100 ml), dried (Na2SO4), filtered and the solvent evaporated in vacuo affording 6.0 g (33percent) of almost regioisomer pure 2-amino-7-(1,3-dioxo-1,3-dihydro-isoindol-2-ylmethyl)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester as a solid.2-amino-5-(1,3-dioxo-1,3'-dihydro-isoindol-2-ylmethyl)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester1H NMR (300 MHz, CDCl3) δ1.50 (s, 9H), 2.54-2.63 (m, 1H), 2.84-2.90 (m, 1H), 3.79 (q, 1H), 3.96-4.04 (m, 2H), 4.48-4.62 (m, 2H), 5.91 (bs, 2H, NH2), 7.70 (m, 2H), 7.84 (m, 2H).2-amino-7-(1,3-dioxo-1,3-dihydro-isoindol-2-ylmethyl)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester1H NMR (300 MHz, CDCl3) δ 1.50 (s, 9H), 2.71-2.90 (m, 2H), 3.67-3.77, (m, 2H), 4.02-4.15 (m, 2H), 4.90 (m, 1H), 6.04 (bs, 2H, NH2), 7.70 (m, 2H), 7.84 (m, 2H).To a solution of 2-amino-7-(1,3-dioxo-1,3-dihydro-isoindol-2-ylmethyl)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester (6.0 g, 0.014 mol) in ethanol (100 ml) was added hydrazine-hydrate (1.4 ml, 0.029 mol). The mixture was stirred at reflux temperature for 1 h. The cooled reaction mixture was filtered and the solvent evaporated in vacuo. The residue was dissolved in diethyl ether (200 ml) and washed with water (100 ml), brine (100 ml), dried (Na2SO4), filtered and the solvent evaporated in vacuo affording 2.9 g (71percent) of 2-amino-7-aminomethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester as an oil.To a ice cooled mixture of 2-amino-7-aminomethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester (1.4 g, 4.92 mmol), triethylamine (2 ml) in dichloromethane (100 ml) was added dropwise a solution of benzo[1,3]dioxole-5-carbonyl chloride (1.0 g, 5.41 mmol) in dichloromethane (25 ml) during 1.5 h. The ice cooled reaction mixture was stirred for an additional 0.5 h. The volatiles were evaporated in vacuo and the residue was dissolved in ethyl acetate (200 ml) and washed with water (2.x.100 ml), brine (100 ml), dried (Na2SO4), filtered and the solvent evaporated in vacuo. The residue (2 g) was subjected to flash column chromatography (1 l silicagel) using a mixture of ethyl acetate/hexane (1:2) as eluant. Pure fractions were collected affording after evaporation in vacuo 0.3 g (14percent) of 2-amino-7-(((benzo[1,3]dioxole-5-carbonyl)amino)-methyl)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester as an oil.TLC: Rf=0.44 (ethyl acetate/heptane 1:1)A mixture of the above 2-amino-7-(((benzo[1,3]dioxole-5-carbonyl)amino)methyl)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl, ester (0.3 g, 0.69 mmol), imidazol-1-yl-oxo-acetic acid tert-butyl ester (0.16 g, 0.83 mmol) in dry tetrahydrofuran (50 ml) was stirred at room temperature for 16 h. The volatiles were evaporated in vacuo and the residue was dissolved in ethyl acetate (100 ml) and washed with water (2.x.50 ml), brine (50 ml), dried (Na2SO4), filtered and the solvent evaporated in vacuo. The residue (0.35 g) was subjected to flash column chromatography (500 ml silicagel) using a mixture of ethyl acetate/hexane (1:1) as eluant. Pure fractions were collected and the solvent evaporated in vacuo. The residue was trituated with diethyl ether (5 ml), filtered off and dried in vacuo at 50° C. for 5 h which afforded 0.17 g (44percent) of 7-(((benzo[1,3]dioxole-5-carbonyl)amino)methyl)-2-(tert-butoxyoxalyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid tert-butyl ester as a solid.TLC: Rf=0.37 (ethyl acetate/heptane 1.1).The above di-tert-butyl ester (0.17 g, 0.30 mmol) was dissolved in 25percent trifluoroacetic acid in dichloromethane (20 ml). The reaction was stirred at room temperature for 5.5 h. The volatiles were evaporated in vacuo and the residue trituated with diethyl ether (10 ml). The precipitate was filtered off, washed with diethyl ether, dried in vacuo at 50° C. for 72 h which afforded 100 mg (74percent) of the title compound as a solid.M.p.: 277-230° C.Calculated for C19H16N2O9S, 0.5.x.H2O; C, 49.89percent; H, 3.75percent; N, 6.12percent. Found: C, 50.02percent; H, 3.68percent; N, 5.98percent.
84% With trifluoroacetic acid In dichloromethane at 20 - 25℃; for 24 h; Step 1. Preparation of C95. A solution of C94 (50.0 g, 189.9 mmol) indichloromethane (100 mL) was treated with trifluoroacetic acid (50.0 mL, 661.3 mmol). The reaction mixture was stirred at room temperature for 24 hours. The dichloromethane and trifluoroacetic acid was displaced with toluene (4 x 150 mL) using vacuum, to a final volume of 120 mL. The solution was added to heptane (250 mL) and the solid was collected by filtration. The solid was washed with a mixture of toluene and heptane (1 : 3, 60 mL), followed by heptane (2 x 80 mL) and dried under vacuum at 50 °C for 19 hours to afford C95 as a solid. Yield: 30.0 g, 158 mmol, 84percent. 1H NMR (400 MHz, CDCI3) δ 9.66 (s, 1 H), 7.86 - 7.93 (m, 2H), 7.73 - 7.80 (m, 2H), 4.57 (s, 2H). HPLC retention time 5.1 minutes; column: Agilent Extended C-18 column (75 mm x 3 mm, 3.5 μηη); column temperature 45 °C; flow rate 1.0 mL / minute; detection UV 230 nm; mobile phase: solvent A = acetonitrile (100percent), solvent B = acetonitrile (5percent) in 10 mM ammonium acetate; gradient elusion: 0-1.5 minutes solvent B (100percent), 1.5-10.0 minutes solvent B (5percent), 10.0-13.0 minutes solvent B (100percent); total run time 13.0 minutes.
80% at 100℃; for 0.5 h; The foregoing compound (3 g) and hydrochloric acid (15mL) were heated at 100 °C for 30minutes with stirring. The product crystallised on cooling. It was collected and purified from diethyl ether. Yield 80percent;Elemental analysis calculated for C10H7NO3 (189.17): C 63.4,H 3.7, N 7.4; found: C 62.4, H 3.4, N 7.5. 1H NMR (300MHz, CDCl3): δ9.62 (s, 1H), 7.85–7.65 (m, 4H), 4.45 (s, 2H). ES-MS:m/z 190. IR: ν(C=O) 1721 cm−1.
56%
Stage #1: With hydrogenchloride; water In tetrahydrofuran at 20℃; for 20 h;
A.7.1 Synthesis of (1,3-dioxo-1 ,3-dihydro-isoindol-2-yl)-acetaldehydeTo a solution of phthalimideacetaldehyde diethylacetal (10 g) in dry THF (57 mL), was added aq 6N HCI (207 mL) and the mixture was stirred at rt for 20 h. The reaction mixture was concentrated in vacuo, treated carefully with sat. NaHCOs solution and extracted with DCM. The combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo to yield the title compound as a white solid (4.53 g, 56percent).
56% With hydrogenchloride In tetrahydrofuran at 20℃; for 20 h; To a solution of phthalimideacetaldehyde diethylacetal (10 g) in dry THF (57 mL), was added aq 6N HCl (207 mL) and the mixture was stirred at rt for 20 h. The reaction mixture was concentrated in vacuo, treated carefully with sat. NaHCO3 solution and extracted with DCM. The combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo to yield the title compound as a white solid (4.53 g, 56percent).1H-NMR (CDCl3): δ=4.55 (s, 2H); 7.75 (dd, 2H); 7.91 (dd, 2H); 9.6 (s, 1H).
55% for 2 h; Reflux Compound 3 was prepared by the condensation of commercially available aminoacetaldehyde diethyl acetal with the phthalic anhydride (1:1 mol ratio), using toluene under reflux, in the presence of a catalytic amount of DMAP (yield 52percent) for 2 h. In the next step, 2-(2,2-diethoxyethyl)isoindoline-1,3-dione (3) underwent acid hydrolysis (sulphuric acid at 70percent) in reflux for 2 h. After the reaction was completed, it was allowed to reach at room temperature and was then cooled to induce precipitation. The formed precipitate was filtered on a sintered funnel with distilled water, yielding 55percent of the pure product. For the synthesis of 5a and 5b, 2-(1,3-dioxoisoindol-2-yl) acetaldehyde (4) reacted with thiosemicarbazide (in the ratio 1:1) (for 5a) or 4-phenyl-3-thiosemicarbazide (for 5b), in ethanol, under reflux with catalytic amount of HCl (4 drops) for 4 h. The reactions were followed by thin layer chromatographic plate analysis. The formed precipitate was filtered on a sintered funnel with ethanol to yield the pure product (yield 76percent for 5a and 70percent for 5b).

Reference: [1] Tetrahedron, 2002, vol. 58, # 9, p. 1719 - 1737
[2] Tetrahedron, 2008, vol. 64, # 28, p. 6794 - 6800
[3] Patent: WO2007/55513, 2007, A1, . Location in patent: Page/Page column 29
[4] Angewandte Chemie - International Edition, 2015, vol. 54, # 33, p. 9668 - 9672[5] Angew. Chem., 2015, vol. 127, # 33, p. 9804 - 9808,5
[6] Journal of Medicinal Chemistry, 2013, vol. 56, # 23, p. 9709 - 9724
[7] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 10, p. 747 - 751
[8] Patent: EP2537855, 2012, A1, . Location in patent: Page/Page column 19
[9] Patent: WO2012/175516, 2012, A1, . Location in patent: Page/Page column 25
[10] Organic Process Research and Development, 2018, vol. 22, # 2, p. 212 - 218
[11] Chemical Communications, 2014, vol. 50, # 2, p. 216 - 218
[12] Patent: US9605297, 2017, B2, . Location in patent: Page/Page column 10; 11
[13] Synthetic Communications, 2003, vol. 33, # 10, p. 1789 - 1795
[14] Patent: EP1214325, 2005, B1, . Location in patent: Page/Page column 47
[15] Patent: US7019026, 2006, B1, . Location in patent: Page/Page column 68
[16] Patent: US7115624, 2006, B1, . Location in patent: Page/Page column 82-84
[17] Patent: WO2012/73138, 2012, A1, . Location in patent: Page/Page column 82-83
[18] Journal of Medicinal Chemistry, 2013, vol. 56, # 13, p. 5541 - 5552
[19] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 15, p. 4667 - 4678
[20] Journal of Chemistry, 2015, vol. 2015,
[21] Journal of the Indian Chemical Society, 1998, vol. 75, # 1, p. 46 - 48
[22] Organic Process Research and Development, 2012, vol. 16, # 12, p. 1897 - 1904
[23] Patent: WO2010/4507, 2010, A1, . Location in patent: Page/Page column 69
[24] Patent: US2011/105491, 2011, A1, . Location in patent: Page/Page column 34-35
[25] European Journal of Medicinal Chemistry, 2016, vol. 111, p. 46 - 57
[26] Recueil des Travaux Chimiques des Pays-Bas, 1932, vol. 51, p. 483,487
[27] Journal of Pharmacy and Pharmacology, 1952, vol. 4, p. 693,705
[28] Tetrahedron, 2003, vol. 59, # 37, p. 7413 - 7422
[29] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 12, p. 4035 - 4046
[30] Patent: US2002/151561, 2002, A1,
[31] Patent: US2005/131017, 2005, A1, . Location in patent: Page/Page column 96
[32] Patent: US2005/131042, 2005, A1, . Location in patent: Page/Page column 65-66
[33] Patent: US2005/148623, 2005, A1, . Location in patent: Page/Page column 129
[34] Patent: WO2005/61487, 2005, A1, . Location in patent: Page/Page column 125
[35] Patent: US2005/159469, 2005, A1, . Location in patent: Page/Page column 64
[36] ChemMedChem, 2010, vol. 5, # 4, p. 523 - 528
[37] Biomacromolecules, 2014, vol. 15, # 5, p. 1612 - 1624
[38] European Journal of Medicinal Chemistry, 2015, vol. 96, p. 491 - 503
[39] Patent: US2015/225399, 2015, A1,
  • 2
  • [ 27328-34-3 ]
  • [ 2913-97-5 ]
YieldReaction ConditionsOperation in experiment
95% With hydrogenchloride; water In acetonitrile at 20℃; for 24 h; Synthesis of (1,3-dioxo-1,3-dihydro-isoindole-2-yl)-acetaldehyde 4: To a stirred solution of compound 3 (0.470 g, 2 mmol) in a round bottom flask containing 10 mL of CH3CN was added 10 mL of 10percent HCl solution. The reaction mixture was stirred at room temperature for 24 h. The organic solvent was evaporated under reduced pressure, and the aqueous residue was extracted with ethyl acetate, dried in anhydrous Na2SO4, and concentrated to give a white solid. The product 4 was obtained in a 95percent yield (0.359 g), m.p 87-88 °C. 1H NMR (300 MHz, CDCl3): δ 4.58 (s, 2H), 7.72-7.80 (m, 2H), 7.84-7.91 (m, 2H), 9.66 (s, 1H).
75% at 80℃; for 2 h; The solution of 2-(2, 2-dimethoxyethyl) isoindoline-1, 3-dione (100 g, 0.425 mol) in 1N HC1 (100 mL) stirred at 80° C for 2 h. The reaction mixture was cooled to room temperature, diluted with water (200 mL) and extracted with ethyl acetate (2 x 200 mL).The combined organic layer was washed with water (2 x 200mL), followed by brine, dried over sodium sulfate and concentrated under vaccue to give the titled compound (60.0 g, 75percent ) as off white solid. LCMS: m/z 190.1 [M+H] ‘H NMR (300 MHz, Chloroform-d) 9.66 (d, J= 0.8 Hz, 1H), 7.92—7.88 (m, 2H), 7.79 —7.74 (m, 2H), 4.57 (d, J= 0.8 Hz, 2H).
75% at 80℃; for 2 h; The solution of 2-(2,2-dimethoxyethyl)isoindoline-l ,3-dione (product of step-2, 100 g, 0.425 mol) in IN HQ (100 mL) was stirred at 80° C for 2 h. The reaction mixture was cooled to room temperature, diluted with water (200 mL) and extracted with ethyl acetate (2 x 200 mL). The combined organic layer was washed with water (2 x 200mL) followed by brine, dried over sodium sulphate and concentrated under vacuum to afford the title compound (60.0 g, 75percent ) as an off white solid. LCMS: nt/z 190.1 [M+H]+; NMR (300 MHz, Chloroform-d) δ 9.66 (d, / = 0.8 Hz, 1H), 7.92 - 7.88 (m, 2H), 7.79 - 7.74 (m, 2H), 4.57 (d, / = 0.8 Hz, 2H).
2.93 g for 1 h; Reflux Intermediate B2-2-(1,3-dioxoisoindolin-2-yl)acetaldehyde To a suspension of intermediate B1 (4.18g) in water (20ml) was added concd.HCl (4ml). The mixture was refluxed for 1h. TLC detection showed that the reaction was complete. The mixture was extracted with dichloromethane threee times. The combined organic phase was washed with brine twice, saturated aq.NaHCO3 solution once, dried over MgSO4, decolored with active carbon and purified by column chromatography (PE/EA=2:1) to give the title compound as a white solid (2.93g). 1H-NMR (CDCl3, 300 MHz) δ4.55 (s, 2H), 7.75 (m, 2H), 7.88 (m, 2H), 9.65 (s, 1H).
2.93 g With hydrogenchloride In waterReflux To a suspension of intermediate Bi (4.i8 g) in water (20 ml) was added concd.HC1 (4 ml). The mixture was refluxed for i h. TLC detection showed that the reaction was complete. The mixture was extracted with dichioromethane three times. The combined organic phase was washed with brine twice, saturated aq.NaHCO3 solution once, dried over MgSO4, decolored with active carbon and purified by column chromatography (PE/EA=2: i) to give the title compound as a white solid (2.93 g). ‘H-NMR (CDC13, 300 MHz) ö4.55 (s, 2H), 7.75 (m, 2H), 7.88 (m, 2H), 9.65 (s, iH).
2.93 g With hydrogenchloride In water for 1 h; 12.14 g of phthalimide potassium salt, 8.9 g of potassium iodide and 30.95 g of acetamide were mixed to a temperature of 130 ° CAfter solid melting, 10 mL of 2-bromoacetaldehyde dimethyl acetal was added. The mixture was allowed to stand for 5 hours. After cooling, the mixture was diluted with water and stirred to give 10 g of a crude solid which was 2- (2,2-dimethoxyethyl) isoindole-1,3-dione. 4.18 g of crude product was suspended in 20 mL of water and 4 mL of concentrated hydrochloric acid was added for 1 hour. After cooling, the dichloromethane was extracted three times and the dichloromethane layer was washed three times with brine and dried over anhydrous magnesium sulfate. The filtrate was concentrated to give 2.93 g of a white solid.

Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 4, p. 426 - 428
[2] Patent: WO2014/111871, 2014, A1, . Location in patent: Page/Page column 122
[3] Patent: WO2016/12958, 2016, A1, . Location in patent: Page/Page column 26
[4] Tetrahedron Letters, 2001, vol. 42, # 2, p. 315 - 317
[5] Monatshefte fur Chemie, 2003, vol. 134, # 12, p. 1641 - 1649
[6] Patent: EP2725024, 2014, A1, . Location in patent: Paragraph 0103; 0181
[7] Patent: US2014/171431, 2014, A1, . Location in patent: Paragraph 0528
[8] Patent: CN103864754, 2016, B, . Location in patent: Paragraph 0695; 0696
[9] Patent: WO2018/132326, 2018, A1, . Location in patent: Page/Page column 19
  • 3
  • [ 3891-07-4 ]
  • [ 2913-97-5 ]
Reference: [1] Organic and Biomolecular Chemistry, 2011, vol. 9, # 10, p. 3817 - 3824
[2] Angewandte Chemie - International Edition, 2007, vol. 46, # 24, p. 4527 - 4529
[3] Synthetic Communications, 2009, vol. 39, # 1, p. 29 - 47
[4] Synthesis, 2003, # 18, p. 2805 - 2810
[5] Synlett, 2003, # 10, p. 1539 - 1541
[6] Journal of Medicinal Chemistry, 2012, vol. 55, # 6, p. 2846 - 2857
[7] Organic Process Research and Development, 2005, vol. 9, # 5, p. 577 - 582
[8] Journal of Medicinal Chemistry, 2017, vol. 60, # 5, p. 2135 - 2141
  • 4
  • [ 3891-07-4 ]
  • [ 26412-87-3 ]
  • [ 2913-97-5 ]
YieldReaction ConditionsOperation in experiment
32% With triethylamine In dichloromethane; dimethyl sulfoxide Reference Example 64
1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetaldehyde
To a solution of N-(2-hydroxyethyl)phthalimide (1.92 g, 10 mmol) and triethylamine (7 mL, 50 mmol) in DMSO (25 mL) was added solid pyridine sulfur trioxide (4.8 g, 30 mmol) by portions.
The resulting mixture was stirred at room temperature for 1 h.
The reaction mixture is poured into a mixture of CH2Cl2 and 0.5N aq. citric acid.
The layers were separated and the organic layer was washed with water and brine.
The organic phase was dried (Na2SO4), and the solvent was removed in vacuo.
The resultant residue was purified by flash chromatography (SiO2, 1:1 ethyl acetate/hexane) to provide the title compound (0.6 g, 32percent). MS 190 (M+H)+.
Reference: [1] Patent: US6613747, 2003, B2,
[2] Patent: US2002/115620, 2002, A1,
  • 5
  • [ 5428-09-1 ]
  • [ 2913-97-5 ]
Reference: [1] Synthetic Communications, 2006, vol. 36, # 24, p. 3743 - 3747
[2] Journal of the Chinese Chemical Society (Taipei, Taiwan), 1993, vol. 40, # 6, p. 581 - 586
[3] Organic Letters, 2004, vol. 6, # 20, p. 3541 - 3544
  • 6
  • [ 6780-38-7 ]
  • [ 2913-97-5 ]
Reference: [1] Liebigs Annalen der Chemie, 1988, p. 537 - 542
  • 7
  • [ 78902-09-7 ]
  • [ 76-05-1 ]
  • [ 2913-97-5 ]
Reference: [1] Patent: EP874849, 2001, B1,
[2] Patent: US5714487, 1998, A,
[3] Patent: US6284757, 2001, B1,
  • 8
  • [ 85-44-9 ]
  • [ 2913-97-5 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1932, vol. 51, p. 483,487
[2] Tetrahedron Letters, 2012, vol. 53, # 4, p. 426 - 428
[3] Patent: WO2014/111871, 2014, A1,
[4] European Journal of Medicinal Chemistry, 2015, vol. 96, p. 491 - 503
[5] Patent: WO2016/12958, 2016, A1,
[6] European Journal of Medicinal Chemistry, 2016, vol. 111, p. 46 - 57
[7] Patent: WO2018/132326, 2018, A1,
  • 9
  • [ 574-98-1 ]
  • [ 2913-97-5 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 17, p. 2905 - 2908
  • 10
  • [ 81068-59-9 ]
  • [ 2913-97-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1981, # 10, p. 3601 - 3641
  • 11
  • [ 81068-59-9 ]
  • [ 15362-01-3 ]
  • [ 2913-97-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1981, # 10, p. 3601 - 3641
  • 12
  • [ 1074-82-4 ]
  • [ 2913-97-5 ]
Reference: [1] Journal of Pharmacy and Pharmacology, 1952, vol. 4, p. 693,705
[2] Journal of Chemistry, 2015, vol. 2015,
[3] Patent: CN103864754, 2016, B,
  • 13
  • [ 136918-14-4 ]
  • [ 2913-97-5 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 10, p. 747 - 751
  • 14
  • [ 52096-60-3 ]
  • [ 2913-97-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1981, # 10, p. 3601 - 3641
[2] Journal of Chemical Research, Miniprint, 1981, # 10, p. 3601 - 3641
  • 15
  • [ 91-22-5 ]
  • [ 6780-38-7 ]
  • [ 2913-97-5 ]
Reference: [1] Chemische Berichte, 1922, vol. 55, p. 3175
  • 16
  • [ 81068-58-8 ]
  • [ 2913-97-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1981, # 10, p. 3601 - 3641
[2] Journal of Chemical Research, Miniprint, 1981, # 10, p. 3601 - 3641
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2913-97-5 ]

Aldehydes

Chemical Structure| 2436-29-5

[ 2436-29-5 ]

3-(1,3-Dioxoisoindolin-2-yl)propanal

Similarity: 0.96

Chemical Structure| 926307-99-5

[ 926307-99-5 ]

1-Oxoisoindoline-5-carbaldehyde

Similarity: 0.89

Chemical Structure| 1260664-94-5

[ 1260664-94-5 ]

3-Oxoisoindoline-5-carbaldehyde

Similarity: 0.89

Chemical Structure| 13255-50-0

[ 13255-50-0 ]

4-Formyl-N-isopropylbenzamide

Similarity: 0.85

Chemical Structure| 126534-87-0

[ 126534-87-0 ]

3-Formylbenzamide

Similarity: 0.72

Amides

Chemical Structure| 550-44-7

[ 550-44-7 ]

2-Methylisoindoline-1,3-dione

Similarity: 0.98

Chemical Structure| 5428-09-1

[ 5428-09-1 ]

2-Allylisoindoline-1,3-dione

Similarity: 0.98

Chemical Structure| 2436-29-5

[ 2436-29-5 ]

3-(1,3-Dioxoisoindolin-2-yl)propanal

Similarity: 0.96

Chemical Structure| 30250-67-0

[ 30250-67-0 ]

2-(2-Aminoethyl)isoindoline-1,3-dione hydrochloride

Similarity: 0.92

Chemical Structure| 7223-50-9

[ 7223-50-9 ]

N-Propargylphthalimide

Similarity: 0.92

Related Parent Nucleus of
[ 2913-97-5 ]

Indolines

Chemical Structure| 550-44-7

[ 550-44-7 ]

2-Methylisoindoline-1,3-dione

Similarity: 0.98

Chemical Structure| 5428-09-1

[ 5428-09-1 ]

2-Allylisoindoline-1,3-dione

Similarity: 0.98

Chemical Structure| 2436-29-5

[ 2436-29-5 ]

3-(1,3-Dioxoisoindolin-2-yl)propanal

Similarity: 0.96

Chemical Structure| 30250-67-0

[ 30250-67-0 ]

2-(2-Aminoethyl)isoindoline-1,3-dione hydrochloride

Similarity: 0.92

Chemical Structure| 7223-50-9

[ 7223-50-9 ]

N-Propargylphthalimide

Similarity: 0.92